ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Clinical Implications of Tacrolimus Time in Therapeutic Range in Urban Renal Transplant Recipients Under an Early Corticosteroid Withdrawal Protocol

D. Pierce, P. West-Thielke, Z. Hajjiri, S. Gaitonde, I. Tzvetanov, E. Benedetti, A. Lichvar

University of Illinois at Chicago, Chicago, IL

Meeting: 2020 American Transplant Congress

Abstract number: B-111

Keywords: FK506, Immunosuppression, Kidney transplantation

Session Information

Date: Saturday, May 30, 2020

Session Name: Poster Session B: Kidney Immunosuppression: Novel Regimens and Drug Minimization

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

Related Abstracts
  • Tacrolimus Time in Therapeutic Range Predicts Adverse Clinical Outcomes in the First Year of Kidney Transplant.
  • Time within Therapeutic Range: A Comparison of Three Tacrolimus Formulations in Renal Transplant Recipients

*Purpose: Tacrolimus displays wide inter- and intra-patient variability, necessitating therapeutic drug monitoring. Assessing the duration of time in therapeutic range (TTR) is an additional tool to assess this drug therapy. The purpose of this study is to determine the impact of tacrolimus TTR on 12-month biopsy-proven rejection in an early corticosteroid withdrawal (ESW) population.

*Methods: Adult isolated renal transplant (RT) recipients maintained on tacrolimus between 1/1/2015 and 12/31/2018 were screened. Patients who underwent ABO incompatible, positive flow crossmatch RT, died <90 days of RT, were lost to follow-up <12 months post-transplant, or on non-protocol tacrolimus regimens were excluded. High tacrolimus TTR (TTR-H) and low tacrolimus TTR (TTR-L) were differentiated using whole cohort median. The primary outcome was to compare the incidence of 12-month biopsy-proven acute rejection (BPAR). Secondary outcomes included comparing rejection subtypes, presence of donor-specific antibody (DSA) and de novo DSA (dnDSA), and allograft function at 12 months. Tacrolimus TTR was calculated with the Rosendaal method using protocol goal tacrolimus levels (days 0 to 60: 8 – 12 ng/mL and beyond day 60: 5 – 10 ng/mL). Erroneous tacrolimus levels were excluded.

*Results: Patient demographics are demonstrated in table 1. Overall, BPAR was numerically higher but not statistically significant (TTR-L 19.5% vs TTR-H 10.6%, p=0.06). More antibody-mediated rejection occurred in the TTR-L group (8.0% vs 2.3%, p = 0.04). Incidence of DSA (figure 1) was significantly higher in TTR-L patients (36.7% vs. 16.7%, p=0.001) and dnDSA formation was also numerically higher (TTR-L 16.7% vs TTR-H 9.9%, p=0.18). There was no difference in eGFR at 12 months (p=0.29).

*Conclusions: In an ESW population, TTR-L was associated with a higher incidence of DSA and antibody-mediated rejection. Future studies to determine TTR thresholds in the setting of ESW are warranted.

 border=

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Pierce D, West-Thielke P, Hajjiri Z, Gaitonde S, Tzvetanov I, Benedetti E, Lichvar A. Clinical Implications of Tacrolimus Time in Therapeutic Range in Urban Renal Transplant Recipients Under an Early Corticosteroid Withdrawal Protocol [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/clinical-implications-of-tacrolimus-time-in-therapeutic-range-in-urban-renal-transplant-recipients-under-an-early-corticosteroid-withdrawal-protocol/. Accessed February 25, 2021.

« Back to 2020 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Home
  • Search
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.